Advertisement

European Journal of Dermatology

, Volume 28, Issue 5, pp 718–720 | Cite as

Treatments and outcomes in juvenile linear scleroderma: a narrative systematic review

  • Laetitia Le Sache De Peufheiloux
  • Maeva Benamara-Levy
  • Marie-Claude Dionne
  • Christine Bodemer
  • Sophie Leducq
  • Mahtab Samimi
  • Annabel MaruaniEmail author
Article
  • 4 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Peterson LS, Nelson AM, Su WP. Classification of morphea (localized scleroderma). Mayo Clin Proc 1995; 70: 1068–76.CrossRefGoogle Scholar
  2. 2.
    Zulian F, Athreya BH, Laxer R, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology 2006; 45: 614–20.Google Scholar
  3. 3.
    Peterson LS, Nelson AM, Su WP, Mason T, O’Fallon WM, Gabriel SE. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960–1993. J Rheumatol 1997; 24: 73–80.Google Scholar
  4. 4.
    Saxton–Daniels S, Jacobe HT. An evaluation of long–term outcomes in adults with pediatric onset morphea. Arch Dermatol 2010; 146: 1044–5.Google Scholar
  5. 5.
    Piram M, Mc Cuaig CC, Saint–Cyr C, et al. Short–and longterm outcome of linear morphoea in children. Br J Dermatol 2013; 169: 1265–71.CrossRefGoogle Scholar
  6. 6.
    Li S, Feldman B, Higgins G, Haines K, Punaro M, O’Neil K. Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists. J Rheumatol 2010; 37: 175–81.CrossRefGoogle Scholar
  7. 7.
    Zulian F, Martini G, Vallongo C, et al. Methotrexate treatment in juvenile localized scleroderma: a randomized, double–blind, placebocontrolled trial. Arthritis Rheum 2011; 63: 1998–2006.CrossRefGoogle Scholar
  8. 8.
    Kreuter A, Hyun J, Stucker M, Sommer A, Altmeyer P, Gambichler T. A randomized controlled study of low dose UVA1, medium dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol 2006; 54: 440–7.CrossRefGoogle Scholar
  9. 9.
    El–Mofty M, Mostafa W, El Darouty M, et al. Different low doses of broad band UVA in the treatment of morphea and systemic sclerosis. Photodermatol Photoimmunol Photomed 2004; 20: 148–56.CrossRefGoogle Scholar
  10. 10.
    Li SC, Torok KS, Pope E, et al. Development of concensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res 2012; 64: 1175–85.Google Scholar

Copyright information

© John Libbey Eurotext 2018

Authors and Affiliations

  • Laetitia Le Sache De Peufheiloux
    • 1
  • Maeva Benamara-Levy
    • 2
  • Marie-Claude Dionne
    • 1
  • Christine Bodemer
    • 1
  • Sophie Leducq
    • 2
  • Mahtab Samimi
    • 2
  • Annabel Maruani
    • 2
    • 3
    Email author
  1. 1.Department of Dermatology and Pediatric Dermatology, Necker-Enfants Malades HospitalAssistance Publique Hôpitaux de Paris (APHP)ParisFrance
  2. 2.Department of DermatologyCentre Hospitalier Régional Universitaire (CHRU) ToursTours Cedex 9France
  3. 3.Universities of Nantes and ToursSPHERE-INSERM 1246ToursFrance

Personalised recommendations